158 related articles for article (PubMed ID: 37507241)
21. Active surveillance for small renal masses diagnosed in elderly or comorbid patients: looking for the best treatment strategy.
Brunocilla E; Borghesi M; Schiavina R; Palmieri F; Pernetti R; Monti C; Martorana G
Actas Urol Esp; 2014; 38(1):1-6. PubMed ID: 24126193
[TBL] [Abstract][Full Text] [Related]
22. The role of surveillance in the management of small renal masses.
Volpe A
ScientificWorldJournal; 2007 Apr; 7():860-8. PubMed ID: 17619771
[TBL] [Abstract][Full Text] [Related]
23. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
[TBL] [Abstract][Full Text] [Related]
24. A Review on the Management of Small Renal Masses: Active Surveillance Versus Surgery.
Marra G; Oderda M; Allasia M; Munegato S; Joniau S; Gontero P
Anticancer Agents Med Chem; 2018; 18(7):940-950. PubMed ID: 29141564
[TBL] [Abstract][Full Text] [Related]
25. The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative Experience.
Paudel R; Madan R; Qi J; Ferrante S; Cher ML; Lane BR; George AK; Semerjian A; Ginsburg KB
J Urol; 2023 Jan; 209(1):170-179. PubMed ID: 36265120
[TBL] [Abstract][Full Text] [Related]
26. Active surveillance protocol in prostate cancer in Portugal.
Silva Gaspar SR; Fernandes M; Castro A; Oliveira T; Santos Dias J; Palma Dos Reis J
Actas Urol Esp (Engl Ed); 2022; 46(6):329-339. PubMed ID: 35277378
[TBL] [Abstract][Full Text] [Related]
27. Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists.
Kim SP; Shah ND; Meropol NJ; Tilburt JC; Nguyen PL; Yu JB; Abouassaly R; Kim A; Gross CP
Eur Urol Oncol; 2019 Mar; 2(2):189-195. PubMed ID: 31017095
[TBL] [Abstract][Full Text] [Related]
28. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study.
Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB
Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123
[TBL] [Abstract][Full Text] [Related]
29. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
Ehdaie B; Assel M; Benfante N; Malhotra D; Vickers A
Eur Urol; 2017 Jun; 71(6):866-871. PubMed ID: 28129893
[TBL] [Abstract][Full Text] [Related]
30. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness Analysis of
Su ZT; Patel HD; Huang MM; Meyer AR; Pavlovich CP; Pierorazio PM; Javadi MS; Allaf ME; Rowe SP; Gorin MA
Eur Urol Focus; 2021 Jul; 7(4):827-834. PubMed ID: 32115400
[TBL] [Abstract][Full Text] [Related]
32. Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer.
Jain AL; Sidana A; Maruf M; Sugano D; Calio B; Wood BJ; Pinto PA
Urol Oncol; 2019 Mar; 37(3):182.e1-182.e8. PubMed ID: 30522903
[TBL] [Abstract][Full Text] [Related]
33. Appropriateness Criteria for Active Surveillance of Prostate Cancer.
Cher ML; Dhir A; Auffenberg GB; Linsell S; Gao Y; Rosenberg B; Jafri SM; Klotz L; Miller DC; Ghani KR; Bernstein SJ; Montie JE; Lane BR;
J Urol; 2017 Jan; 197(1):67-74. PubMed ID: 27422298
[TBL] [Abstract][Full Text] [Related]
34. Urologists' Perceptions of Active Surveillance and Their Recommendations for Low-risk Prostate Cancer Patients.
Xu J; Bock C; Janisse J; Schwartz KL; Triest J; Cher ML; Goodman M
Urology; 2021 Sep; 155():83-90. PubMed ID: 33482128
[TBL] [Abstract][Full Text] [Related]
35. Watchful waiting for small renal masses.
Mattar K; Jewett MA
Curr Urol Rep; 2008 Jan; 9(1):22-5. PubMed ID: 18366970
[TBL] [Abstract][Full Text] [Related]
36. Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists' recommendations for active treatment or active surveillance: a randomized clinical utility trial.
Peabody JW; DeMaria LM; Tamondong-Lachica D; Florentino J; Czarina Acelajado M; Ouenes O; Richie JP; Burgon T
BMC Urol; 2017 Jul; 17(1):51. PubMed ID: 28673277
[TBL] [Abstract][Full Text] [Related]
37. Active surveillance of small renal masses: progression patterns of early stage kidney cancer.
Jewett MA; Mattar K; Basiuk J; Morash CG; Pautler SE; Siemens DR; Tanguay S; Rendon RA; Gleave ME; Drachenberg DE; Chow R; Chung H; Chin JL; Fleshner NE; Evans AJ; Gallie BL; Haider MA; Kachura JR; Kurban G; Fernandes K; Finelli A
Eur Urol; 2011 Jul; 60(1):39-44. PubMed ID: 21477920
[TBL] [Abstract][Full Text] [Related]
38. Extended Duration of Active Surveillance of Small Renal Masses: A Prospective Cohort Study.
Whelan EA; Mason RJ; Himmelman JG; Matheson K; Rendon RA
J Urol; 2019 Jul; 202(1):57-61. PubMed ID: 30932757
[TBL] [Abstract][Full Text] [Related]
39. Clinical and radiological findings for small renal masses under active surveillance.
Ajami T; Sebastia C; Corominas D; Ribal MJ; Nicolau C; Alcaraz A; Musquera M
Urol Oncol; 2021 Aug; 39(8):499.e9-499.e14. PubMed ID: 34116937
[TBL] [Abstract][Full Text] [Related]
40. Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.
Luckenbaugh AN; Auffenberg GB; Hawken SR; Dhir A; Linsell S; Kaul S; Miller DC;
J Urol; 2017 Mar; 197(3 Pt 1):621-626. PubMed ID: 27663459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
